Cargando…
Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
BACKGROUND: Identifying risk factors predicting acquisition of resistant Pseudomonas aeruginosa will aid surveillance and diagnostic initiatives and can be crucial in early and appropriate antibiotic therapy. We conducted a systematic review examining risk factors of acquisition of resistant P. aeru...
Autores principales: | Raman, Gowri, Avendano, Esther E., Chan, Jeffrey, Merchant, Sanjay, Puzniak, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032536/ https://www.ncbi.nlm.nih.gov/pubmed/29997889 http://dx.doi.org/10.1186/s13756-018-0370-9 |
Ejemplares similares
-
Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
por: Nathwani, Dilip, et al.
Publicado: (2014) -
Pseudomonas infections among hospitalized adults in Latin America: a systematic review and meta-analysis
por: Ponce de Leon, Alfredo, et al.
Publicado: (2020) -
Assessing Rates of Co-Resistance and Patient Outcomes in Multidrug-Resistant Pseudomonas aeruginosa
por: Appaneal, Haley J., et al.
Publicado: (2022) -
Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals
por: Telling, Kaidi, et al.
Publicado: (2018) -
A Multicenter Evaluation of Ceftolozane/Tazobactam Treatment Outcomes in Immunocompromised Patients With Multidrug-Resistant Pseudomonas aeruginosa Infections
por: Hart, Delaney E, et al.
Publicado: (2021)